{"anticipatedPostingDate":"2027-09","denomUnitsSelected":"Participants","description":"Laboratory abnormalities included Hematology and Serum Chemistry. In Hematology (increased : hemoglobin, lymphocytes, leukocytes, and decreased : hemoglobin, lymphocytes, neutrophils, platelets and leukocytes) and In serum chemistry (increased in : alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, bilirubin, calcium corrected for albumin, creatinine, glucose (non-fasting), potassium, sodium, and decreased in albumin, calcium corrected for albumin, glucose (non-fasting), potassium, phosphate and sodium).","reportingStatus":"NOT_POSTED","timeFrame":"From start of treatment up to 37 days after last dose of study drug (approximately up to 7.4 years)","title":"Number of Participants With Laboratory Abnormalities","type":"SECONDARY"}